A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
Research
[키워드] 2000 COVID-19 patient
age
anti-SARS-CoV-2 antibody
antibody
Antibody Response
association
Cancer
cancer patient
cardiovascular risk
Care
caused
Characteristics
Chronic kidney disease
Cohort
Comorbidities
Complete
COVID-19
COVID-19 infection
COVID-19 pandemic
CRP
D-dimer
death
demonstrated
Diabetes Mellitus
diagnosed with COVID-19
Diagnosis
died
disease status
disorder
drug
elevated
epidemiological
ferritin
had no
Hospitalization
Hospitalized
hospitalized patients
hyperlipidemia
Hypogammaglobulinemia
impacted
IMPROVE
Inflammatory marker
inflammatory markers
Inflammatory response
initial
initiated
Intervention
Laboratory
laboratory characteristics
Lung disease
majority
male
Male sex
median
median age
median time
Mortality
Mount Sinai
mounted
Mounting
Multiple myeloma
New York
New York City
obesity
outbreak
outcome
outcomes
pandemic
Patient
PCR
PCR negativity
performed
persistence
polymerase chain
positive PCR
Result
Retrospective study
SARS
SARS-CoV-2
SARS-CoV-2 virus
serological response
significantly
Smoldering multiple myeloma
treated
Treatment
USA
Viral detection
[DOI] 10.1186/s13045-020-00934-x PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13045-020-00934-x PMC 바로가기 [Article Type] Research